Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dimitrios A Karagiannis, Meropi Lygerou, Georgios Papadopoulos, Stamatina A Kabanarou, Miltiadis Aspiotis, Doukas C Dardabounis, Panagiotis G Minakakis, Sofia I Spai, Chrysanthi Koutsandrea, Panagiotis Oikonomidis, Georgia N Pantelopoulou, Olga C Kousidou & Miltiadis Tsilimbaris. (2020) A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study. Clinical Ophthalmology 14, pages 1417-1426.
Read now
Read now
Sobha Sivaprasad & Sesan Oyetunde. (2016) Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion. Clinical Ophthalmology 10, pages 939-946.
Read now
Read now
Dominique Bremond-Gignac. (2016) Investigational drugs for retinal vein occlusion. Expert Opinion on Investigational Drugs 25:7, pages 841-850.
Read now
Read now
Victor Koh, Carol Y. Cheung, Xiang Li, Dechao Tian, Jie Jin Wang, Paul Mitchell, Ching-Yu Cheng & Tien Y. Wong. (2016) Retinal Vein Occlusion in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Disease Study. Ophthalmic Epidemiology 23:1, pages 6-13.
Read now
Read now
Articles from other publishers (25)
Lars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, Karen Basu, Carl J. Danzig, Robyn Guymer, Zdenka Haskova, Jeffrey S. Heier, Aachal Kotecha, Ying Liu, Anat Loewenstein, András Seres, Jeffrey R. Willis, Charles C. Wykoff & Liliana P. Paris. (2023) BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion. Ophthalmology Science 3:3, pages 100302.
Crossref
Crossref
Seenu M Hariprasad, George Joseph, Patrick Gagnon-Sanschagrin, Elizabeth Serra, Subrata Bhattacharyya, Jérôme Bédard, Annie Guérin & Thomas Arno Albini. (2021) Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective. BMJ Open Ophthalmology 6:1, pages e000896.
Crossref
Crossref
Ian L McAllister, Lynne A Smithies, Fred K Chen, David A Mackey & Paul G Sanfilippo. (2021) Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy. BMJ Open Ophthalmology 6:1, pages e000728.
Crossref
Crossref
Minji Ha, Kyungdo Han, Younhea Jung, Daran Kim, Ji-Sun Paik & Kyung-Sun Na. (2021) Is retinal vein occlusion associated with depression symptoms?. Medicine 100:32, pages e26937.
Crossref
Crossref
Haley D'Souza & Kapil G. Kapoor. (2020) Retinal vascular manifestations of obstructive sleep apnea. Current Opinion in Ophthalmology 31:6, pages 508-513.
Crossref
Crossref
Jeany Q. Li, Jan Henrik Terheyden, Thomas Welchowski, Matthias Schmid, Julia Letow, Caroline Wolpers, Frank G. Holz & Robert P. Finger. (2019) Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis. Ophthalmologica 241:4, pages 183-189.
Crossref
Crossref
Wenlan Zhang & Paul Hahn. 2017. Handbook of Venous Thromboembolism. Handbook of Venous Thromboembolism
216
228
.
Justis P. Ehlers, Stephen J. Kim, Steven Yeh, Jennifer E. Thorne, Prithvi Mruthyunjaya, Scott D. Schoenberger & Sophie J. Bakri. (2017) Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion. Ophthalmology 124:9, pages 1412-1423.
Crossref
Crossref
Steven E. Bradshaw, Smeet Gala, Merena Nanavaty, Anshul Shah, Mkaya Mwamburi & Panos Kefalas. (2016) Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion. BMC Ophthalmology 16:1.
Crossref
Crossref
M.J. Abraldes, A. Pareja & M. Roura. (2016) Analysis of costs associated with the management and morbidity of diabetic macular oedema and macular oedema secondary to retinal vein occlusion. Archivos de la Sociedad Española de Oftalmología (English Edition) 91:6, pages 273-280.
Crossref
Crossref
M.J. Abraldes, A. Pareja & M. Roura. (2016) Análisis de los costes asociados al manejo y morbilidad del edema macular diabético y el edema macular secundario a oclusión venosa de la retina. Archivos de la Sociedad Española de Oftalmología 91:6, pages 273-280.
Crossref
Crossref
Ahmet Ozkok, Omar A. Saleh, Douglas K. Sigford, James W. Heroman & Shlomit Schaal. (2015) THE OMAR STUDY. Retina 35:7, pages 1393-1400.
Crossref
Crossref
Steven Yeh, Stephen J. Kim, Allen C. Ho, Scott D. Schoenberger, Sophie J. Bakri, Justis P. Ehlers & Jennifer E. Thorne. (2015) Therapies for Macular Edema Associated with Central Retinal Vein Occlusion. Ophthalmology 122:4, pages 769-778.
Crossref
Crossref
Alan R. Berger, Alan F. Cruess, Filiberto Altomare, Varun Chaudhary, Kevin Colleaux, Mark Greve, Amin Kherani, Efrem D. Mandelcorn, Hugh Parsons, Marc-André Rhéaume & Eric Tourville. (2015) Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus. Ophthalmologica 234:1, pages 6-25.
Crossref
Crossref
Ivan J. Suñer, Jay Margolis, Kimberly Ruiz, Irwin Tran & Paul Lee. (2014) DIRECT MEDICAL COSTS AND RESOURCE USE FOR TREATING CENTRAL AND BRANCH RETINAL VEIN OCCLUSION IN COMMERCIALLY INSURED WORKING-AGE AND MEDICARE POPULATIONS. Retina 34:11, pages 2250-2258.
Crossref
Crossref
Paula Anne Newman-Casey, Maxwell Stem, Nidhi Talwar, David C. Musch, Cagri G. Besirli & Joshua D. Stein. (2014) Risk Factors Associated with Developing Branch Retinal Vein Occlusion Among Enrollees in a United States Managed Care Plan. Ophthalmology 121:10, pages 1939-1948.
Crossref
Crossref
Sang Jun Park, Nam-Kyong Choi, Kyung Ha Seo, Kyu Hyung Park & Se Joon Woo. (2014) Nationwide Incidence of Clinically Diagnosed Central Retinal Artery Occlusion in Korea, 2008 to 2011. Ophthalmology 121:10, pages 1933-1938.
Crossref
Crossref
George L. Spaeth & Swathi C. Reddy. (2014) Imaging of the optic disk in caring for patients with glaucoma: Ophthalmoscopy and photography remain the gold standard. Survey of Ophthalmology 59:4, pages 454-458.
Crossref
Crossref
Sang Jun Park, Nam-Kyong Choi, Kyu Hyung Park & Se Joon Woo. (2014) Nationwide Incidence of Clinically Diagnosed Retinal Vein Occlusion in Korea, 2008 through 2011. Ophthalmology 121:6, pages 1274-1280.
Crossref
Crossref
Paul Hahn, Prithvi Mruthyunjaya & Sharon Fekrat. 2013. Retina. Retina
1039
1049
.
Paul Hahn & Sharon Fekrat. (2012) Best practices for treatment of retinal vein occlusion. Current Opinion in Ophthalmology 23:3, pages 175-181.
Crossref
Crossref
J. W. Kowalski, E. Hayward, S. Mazzi, G. Pardhanani, C. M. Almond, D. Trueman & M. A. Adena. (2013) Valutazione economica del trattamento con impianto intravitreale biodegradabile di desametasone di pazienti affetti da edema maculare secondario a occlusione della vena retinica, in ItaliaEconomic evaluation with dexamethasone biodegradable intravitreal implant for the treatment of patients with macular edema following retinal vein occlusion in Italy. PharmacoEconomics Italian Research Articles 14:1, pages 29-38.
Crossref
Crossref
David J. BrowningDavid J. Browning. 2012. Retinal Vein Occlusions. Retinal Vein Occlusions
279
334
.
M Laouri, E Chen, M Looman & M Gallagher. (2011) The burden of disease of retinal vein occlusion: review of the literature. Eye 25:8, pages 981-988.
Crossref
Crossref
Justis P. Ehlers & Sharon Fekrat. (2011) Retinal Vein Occlusion: Beyond the Acute Event. Survey of Ophthalmology 56:4, pages 281-299.
Crossref
Crossref